Allenex

Stockholm, Sweden Founded: 1998 • Age: 28 yrs Acquired By CareDx
Transplantation diagnostic kits for matching and rejection prevention are developed.

About Allenex

Allenex is a Healthcare company based in Stockholm (Sweden) founded in 1998, and was acquired by CareDx in December 2015. Transplantation diagnostic kits for matching and rejection prevention are developed. The company was acqui-hired. Its focus areas include Life Sciences, Immunology, In Vitro Diagnostic Tests and GvHD.

Company details

Allenex was founded in 1998 in Stockholm, Sweden, within the biotechnology sector focused on transplantation diagnostics. PCR-based kits under the Olerup SSP line are utilized for HLA matching in hematopoietic stem cell and organ transplants. XM-One assays are applied to detect antibodies targeting HLA Class I or II antigens or donor endothelium, supporting rejection avoidance. The company was acquired by CareDx in April 2016.

  • Headquarters Stockholm, Sweden
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website allenex.com
  • Social LinkedIn
  • Acquired by CareDx (Dec 2015)
Key Metrics

Investors in Allenex

Allenex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CareDx.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Medical solutions for transplant patients are developed and provided.
1998caredx.comBrisbane, United States
Premium access

Investor details for Allenex

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Allenex

2 dated milestones of Allenex across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded Allenex is founded.
  2. Exit Acquired by CareDx.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Allenex

Allenex was founded in 1998.

Allenex is headquartered in Stockholm, Sweden.

Allenex was founded in 1998 in Stockholm, Sweden, within the biotechnology sector focused on transplantation diagnostics. PCR-based kits under the Olerup SSP line are utilized for HLA matching in hematopoietic stem cell and organ transplants. XM-One assays are applied to detect antibodies targeting HLA Class I or II antigens or donor endothelium, supporting rejection avoidance. The company was acquired by CareDx in April 2016.

Allenex has 1 investor. Key investors include CareDx.

Yes. Allenex was acquired by CareDx in December 2015.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available